Total Payments
$1,536
2024 Payments
$310.28
Companies
18
Transactions
77
Medicare Patients
9,432
Medicare Billing
$556,339
Payment Breakdown by Category
Food & Beverage$1,467 (95.5%)
Education$68.99 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,467 | 76 | 95.5% |
| Education | $68.99 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $229.65 | 10 | $0 (2023) |
| PFIZER INC. | $203.50 | 12 | $0 (2023) |
| LEO Pharma Inc. | $177.07 | 8 | $0 (2024) |
| GENZYME CORPORATION | $172.20 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $126.79 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $108.78 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $91.12 | 4 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $74.54 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $62.17 | 4 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $51.32 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.28 | 14 | LEO Pharma Inc. ($96.00) |
| 2023 | $739.42 | 38 | GENZYME CORPORATION ($127.86) |
| 2022 | $224.27 | 12 | ABBVIE INC. ($68.85) |
| 2021 | $262.22 | 13 | AbbVie Inc. ($87.39) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $9.16 | General |
| 09/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.19 | General |
| 06/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $68.99 | General |
| 06/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: DERMATOLOGY | ||||||
| 05/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DERMATOLOGY | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Inflammation | ||||||
| 04/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: DERMATOLOGY | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: DERMATOLOGY | ||||||
| 02/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Dermatology | ||||||
| 01/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Dermatology | ||||||
| 10/18/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Podiatry | ||||||
| 09/25/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Immunology | ||||||
| 09/11/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Immunology | ||||||
| 08/29/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 08/28/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: DERMATOLOGY | ||||||
| 08/01/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Dermatology | ||||||
| 07/25/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/24/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.98 | General |
| 07/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,095 | 4,058 | $665,408 | $120,990 |
| 2022 | 18 | 2,275 | 4,847 | $739,566 | $134,102 |
| 2021 | 19 | 2,559 | 5,012 | $824,124 | $154,094 |
| 2020 | 17 | 2,503 | 4,765 | $780,606 | $147,152 |
Total Patients
9,432
Total Services
18,682
Medicare Billing
$556,339
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 509 | 783 | $205,998 | $38,235 | 18.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 244 | 272 | $80,552 | $15,154 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 260 | 260 | $84,785 | $13,593 | 16.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 315 | 408 | $79,860 | $13,012 | 16.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 135 | 148 | $49,002 | $10,001 | 20.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 282 | 1,742 | $33,958 | $6,700 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 62 | $23,094 | $4,471 | 19.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 34 | 39 | $19,191 | $3,592 | 18.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 35 | $18,260 | $3,493 | 19.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 57 | 73 | $10,720 | $2,286 | 21.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $7,227 | $1,605 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,219 | $1,499 | 16.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $8,283 | $1,472 | 17.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 23 | 23 | $8,424 | $1,359 | 16.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $5,614 | $1,153 | 20.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $6,336 | $1,029 | 16.2% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 20 | $5,645 | $940.50 | 16.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 27 | $4,433 | $816.96 | 18.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $3,363 | $421.38 | 12.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 13 | $534.87 | $109.80 | 20.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 65 | $908.12 | $47.91 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 547 | 768 | $204,474 | $35,992 | 17.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 376 | 485 | $95,304 | $15,535 | 16.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 234 | 252 | $76,502 | $14,395 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 234 | 234 | $76,602 | $12,951 | 16.9% |
About Wesley Bull, PA-C
Wesley Bull, PA-C is a Medical healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1225469935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wesley Bull, PA-C has received a total of $1,536 in payments from pharmaceutical and medical device companies, with $310.28 received in 2024. These payments were reported across 77 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,467).
As a Medicare-enrolled provider, Bull has provided services to 9,432 Medicare beneficiaries, totaling 18,682 services with total Medicare billing of $556,339. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Midlothian, TX
- Active Since 12/05/2013
- Last Updated 03/11/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1225469935
Products in Payments
- DUPIXENT (Biological) $298.99
- EUCRISA (Drug) $203.50
- ADBRY (Biological) $177.07
- SKYRIZI (Biological) $126.51
- Sotyktu (Drug) $91.12
- HUMIRA (Biological) $62.96
- Cimzia (Drug) $40.49
- RINVOQ (Biological) $40.18
- VTAMA (Drug) $38.90
- REMICADE (Biological) $34.62
- COSENTYX (Drug) $32.24
- Seysara (Drug) $30.98
- QBREXZA (Drug) $30.32
- Otezla (Drug) $29.81
- ILUMYA (Biological) $21.57
- JUBLIA (Drug) $18.85
- Winlevi (Drug) $18.22
- Erivedge (Biological) $18.15
- Cabtreo (Drug) $16.64
- ARAZLO (Drug) $15.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Midlothian
Nguyet Nguyen, Physician Assistant, PHYSICIAN ASSISTANT
Medical — Payments: $11,754
Medical $11,754
Joshua Harris, Pa, PA
Medical — Payments: $6,580
Medical $6,580
Dustin Bogan, Pa-C, PA-C
Medical — Payments: $2,429
Medical $2,429
Sarah Trezza, P.a, P.A
Medical — Payments: $1,915
Medical $1,915
Mrs. Mamta Patel, Pa-C, PA-C
Medical — Payments: $1,775
Medical $1,775
Lawrence Berndt, P.a.-C, P.A.-C
Medical — Payments: $960.48
Medical $960.48